Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer

Clinical trial NCT03613753 · UNKNOWN

Trial details

NCT number: NCT03613753
Sponsor: ShengFa Su
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Small-cell Lung Cancer

Start date: 2018-06-01
Primary completion: 2020-06-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.